中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
11期
413-414
,共2页
丁苯酞%重度颈内动脉颅内段狭窄%脑血管反应性%临床影响分析
丁苯酞%重度頸內動脈顱內段狹窄%腦血管反應性%臨床影響分析
정분태%중도경내동맥로내단협착%뇌혈관반응성%림상영향분석
Styrene-butadiene brilliant%Severe internal carotid artery stenosis intracranial period%Cerebrovascular reactivity%Clinical impact analysis
目的探讨丁苯酞对重度颈内动脉颅内段狭窄患者脑血管反应性的影响.方法对照组患者仅进行常规临床治疗;研究组患者在进行上述常规治疗的基础上,给予丁苯酞药物联合治疗.观察并记录两组患者治疗前后脑血管反应性变化情况,并于治疗前后分别对患者进行多普勒临床医学影像检查,对检查结果及治疗结果给予统计学分析,得出结论.结果研究组患者经治疗后,脑血管改善程度为(0.24±0.16),明显高于对照组患者经治疗后脑血管改善程度为(0.05±0.03),且P<0.05,两组患者对比结果具有统计学意义.结论对重度颈内动脉颅内段狭窄患者在进行常规治疗的基础上给予丁苯酞药物联合治疗,能够明显提高患者脑血管反应性,从而提高患者临床治疗效果与生活质量,最终保障患者生命安全.
目的探討丁苯酞對重度頸內動脈顱內段狹窄患者腦血管反應性的影響.方法對照組患者僅進行常規臨床治療;研究組患者在進行上述常規治療的基礎上,給予丁苯酞藥物聯閤治療.觀察併記錄兩組患者治療前後腦血管反應性變化情況,併于治療前後分彆對患者進行多普勒臨床醫學影像檢查,對檢查結果及治療結果給予統計學分析,得齣結論.結果研究組患者經治療後,腦血管改善程度為(0.24±0.16),明顯高于對照組患者經治療後腦血管改善程度為(0.05±0.03),且P<0.05,兩組患者對比結果具有統計學意義.結論對重度頸內動脈顱內段狹窄患者在進行常規治療的基礎上給予丁苯酞藥物聯閤治療,能夠明顯提高患者腦血管反應性,從而提高患者臨床治療效果與生活質量,最終保障患者生命安全.
목적탐토정분태대중도경내동맥로내단협착환자뇌혈관반응성적영향.방법대조조환자부진행상규림상치료;연구조환자재진행상술상규치료적기출상,급여정분태약물연합치료.관찰병기록량조환자치료전후뇌혈관반응성변화정황,병우치료전후분별대환자진행다보륵림상의학영상검사,대검사결과급치료결과급여통계학분석,득출결론.결과연구조환자경치료후,뇌혈관개선정도위(0.24±0.16),명현고우대조조환자경치료후뇌혈관개선정도위(0.05±0.03),차P<0.05,량조환자대비결과구유통계학의의.결론대중도경내동맥로내단협착환자재진행상규치료적기출상급여정분태약물연합치료,능구명현제고환자뇌혈관반응성,종이제고환자림상치료효과여생활질량,최종보장환자생명안전.
Objective To study the styrene-butadiene brilliant to severe internal carotid artery stenosis in patients with intracranial segment cerebrovascular reactivity infuence. Methods The patients in control group only in routine clinical treatment; the patients in the conventional treatment on the basis of, give styrene-butadiene brilliant drug combination therapy.Observe and record the two groups before and after treatment in patients with cerebrovascular reactivity changes, and in respectively before and after treatment in patients with doppler clinical medical imaging, the inspection results and the treatment results give statistics analysis, draw the conclusion. Results The patients after treatment, the improvement of the cerebrovascular (0.24±0.16), signifcantly higher than those in the control group after treatment in patients with cerebrovascular improve the level of (0.05±0.03) and P<0.05, the two groups were compared with the results of statistical signifcance. Conclusion The severe internal carotid artery stenosis in patients with intracranial segment routine treatment on the basis of given styrene-butadiene brilliant drug combination therapy can signifcantly improve the patients with cerebrovascular reactivity, so as to improve the clinical treatment effect and quality of life, and ultimately ensuring patients life safety.